NOX Share Price Performance
AU$0.094
-0.04 (-27.69%)
Price AU$0.094
Share PriceAU$0.094
We're Keeping An Eye On Noxopharm's (ASX:NOX) Cash Burn Rate
Jul 29
Noxopharm Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
NOX Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Noxopharm Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.017
- -51.25%
- -173.15%
- 359.3%
About NOX
- Founded
- 2015
- Employees
- n/a
- CEO
- WebsiteView website
Noxopharm Limited, a biotech company, engages in the discovering and developing treatments for cancer and inflammation, and mRNA vaccines in Australia. It develops Sofra, a platform that focuses on the development of immunomodulators for mRNA vaccines and mRNA therapeutics, as well as for the treatment of autoimmune diseases; and Chroma technology platform to develop CRO-67 dual-cell therapy drug for the treatment of pancreatic cancer and various molecules for the treatment of autoimmune disease and hyperinflammatory conditions. The company also develops orphan drug designations to treat less common disease; and IONIC program with Veyonda, which is combined with the Bristol Myers Squibb checkpoint inhibitor Opdivo for the treatment of various solid tumor types. The company was incorporated in 2015 and is based in Glenhaven, Australia.
